Inactivation of C3a and C5a octapeptides by carboxypeptidase R and carboxypeptidase N.
about
Bench-to-bedside review: functional relationships between coagulation and the innate immune response and their respective roles in the pathogenesis of sepsisInflammation and haemostasisProtein-based therapies for acute lung injury: targeting neutrophil extracellular trapsC5a mutants are potent antagonists of the C5a receptor (CD88) and of C5L2: position 69 is the locus that determines agonism or antagonismComplement System Part II: Role in ImmunityA novel function of thrombin-activatable fibrinolysis inhibitor during rat liver regeneration and in growth-promoted hepatocytes in primary cultureTissue factor pathway inhibitor and thrombin activatable fibrinolytic inhibitor plasma levels following burn and septic injuries in ratsAnalytical Prediction of the Spatiotemporal Distribution of Chemoattractants around Their Source: Theory and Application to Complement-Mediated Chemotaxis.A carboxypeptidase inhibitor from the tick Rhipicephalus bursa: isolation, cDNA cloning, recombinant expression, and characterization.Thrombomodulin mutations in atypical hemolytic-uremic syndrome.Biochemical characterization of bovine plasma thrombin-activatable fibrinolysis inhibitor (TAFI).Inactivation of the complement anaphylatoxin C5a by secreted products of parasitic nematodes.Modulation of procarboxypeptidase R (ProCPR) activation by complementary peptides to thrombomodulin.Thrombin activatable fibrinolysis inhibitor (TAFI) at the interface between coagulation and fibrinolysis.Differential regulation of endothelial cell activation by complement and interleukin 1alphaProtein C pathway in sepsis.Inflammation and thrombosis.Thrombomodulin.Carboxypeptidase U (TAFIa): a new drug target for fibrinolytic therapy?Thrombin-activatable procarboxypeptidase B regulates activated complement C5a in vivo.Targeted disruption of the gene encoding the murine small subunit of carboxypeptidase N (CPN1) causes susceptibility to C5a anaphylatoxin-mediated shock.Activated thrombin-activatable fibrinolysis inhibitor (TAFIa) attenuates breast cancer cell metastatic behaviors through inhibition of plasminogen activation and extracellular proteolysis.Lutein Leads to a Decrease of Factor D Secretion by Cultured Mature Human Adipocytes.Novel C5a regulators in inflammatory disease.The proinflammatory mediators C3a and C5a are essential for liver regenerationThrombin-thrombomodulin connects coagulation and fibrinolysis: more than an in vitro phenomenon.Thrombin activatable fibrinolysis inhibitor (TAFI)--how does thrombin regulate fibrinolysis?C5a inhibitor protects against ischemia/reperfusion injury in rat small intestineMaternal Par4 and platelets contribute to defective placenta formation in mouse embryos lacking thrombomodulin.RNA-binding protein HuR interacts with thrombomodulin 5'untranslated region and represses internal ribosome entry site-mediated translation under IL-1 beta treatment.Regulation of tissue inflammation by thrombin-activatable carboxypeptidase B (or TAFI).Insights into thrombin activatable fibrinolysis inhibitor function and regulation.Overview of complement activation and regulationThrombomodulin/activated protein C system in septic disseminated intravascular coagulationReincarnation of ancient links between coagulation and complement.Hypersensitivity to intravenous iron: classification, terminology, mechanisms and managementStructure-function relationships in thrombin-activatable fibrinolysis inhibitor.Endothelial cells: source, barrier, and target of defensive mediators.The roles of selected arginine and lysine residues of TAFI (Pro-CPU) in its activation to TAFIa by the thrombin-thrombomodulin complexThrombin-activatable fibrinolysis inhibitor influences disease severity in humans and mice with pneumococcal meningitis.
P2860
Q24794692-8DDF3DBD-0ACA-48B2-9DF9-77E508BE95D0Q26823258-E3863841-06C1-415E-A2E7-EACDEF922991Q26852032-D36A7B47-E1EE-4A10-932C-61AEB5F19268Q28211612-C02BDF34-46F9-4855-81BA-951026024A13Q28263460-AE8B7E3F-DE1E-4A86-9895-5993F543EDF9Q28571160-CFDA34D3-02E7-477C-B505-0D65D97C936DQ28573067-AEF1EAE4-8905-4B25-9444-8CC4FCAFDC87Q30853485-8984A62C-0386-406B-9512-765611D6EC77Q33209290-F2D2B74E-3AA5-48DC-A155-FC80C8EE697CQ33385474-B7E1F084-6B5F-457A-B0D5-6E4956DDF92CQ33439281-13F0597F-17D4-4237-86EE-D52AC64D0E85Q33781464-208E4F3E-000E-4D6D-9696-338677C2A4ECQ34194108-BFBEBE58-E8BD-46FA-A857-A77AC79E12C3Q34391045-4F8CFAD8-69C3-4C3B-87CA-ABB394A8A011Q34803633-1511E1E3-6417-4F47-8992-B924FF544029Q35055016-237ADEF0-0F57-4FA0-A32C-14235010C0D8Q35181574-F968B268-1DAD-4EFE-8D28-0F53E67B275AQ35181628-C997EFBA-394C-4FC2-9B5A-287DA9CE876AQ35208114-C50927F3-4736-432B-96B2-AEC704BBEC0AQ35642856-CD470D99-A128-4705-9792-1DC17DDDAD3CQ35882816-D3DB34DC-EB5B-4757-81AC-87E8B83ECBC5Q36028684-2A92E940-7735-488C-A2FB-1426D62EF8DBQ36173190-CD370076-EF28-40B1-9DCB-3D94C6CF5D55Q36196446-A6921738-7368-4A7B-B728-B84AD5D0E81FQ36371713-2AD8EECD-923A-4F27-91E2-0C3C1A7AE530Q36384872-62C386D4-4E84-4347-9157-4CE84182D9A7Q36606627-186E48EB-E7C3-4616-B5A7-320DA8C7F71AQ36762146-6CD5DAE5-4426-405C-BC9D-882C389A55F8Q36787588-1B209155-12D0-43DA-AF63-2C36ABDC9F56Q36854879-6510AFAB-8272-45A4-A715-85279E408F26Q37244922-FC897F7E-F48A-4E15-9AB7-4152CC210A2BQ38117742-8300146E-FAB6-4680-BA9A-C584507D3D1DQ38155650-FA0092E8-D616-472C-BD3D-2A464CE15B39Q38364209-A65DCA50-3186-4E48-BD80-6166CA93AAFEQ38543278-DC91A06E-E448-41A8-BBBA-C90906A06015Q38564991-77BCBEDC-F821-4516-B926-C921232C39A7Q38703066-28E87EE8-539E-45A0-8209-746898A62999Q38991026-8A4817C4-B949-430B-859D-5159804DC847Q39906372-412727B7-BDAB-4A54-8629-B84DD790C61CQ40573437-23769A0E-E462-4FF0-98BB-935A43B52A83
P2860
Inactivation of C3a and C5a octapeptides by carboxypeptidase R and carboxypeptidase N.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Inactivation of C3a and C5a octapeptides by carboxypeptidase R and carboxypeptidase N.
@ast
Inactivation of C3a and C5a octapeptides by carboxypeptidase R and carboxypeptidase N.
@en
Inactivation of C3a and C5a octapeptides by carboxypeptidase R and carboxypeptidase N.
@nl
type
label
Inactivation of C3a and C5a octapeptides by carboxypeptidase R and carboxypeptidase N.
@ast
Inactivation of C3a and C5a octapeptides by carboxypeptidase R and carboxypeptidase N.
@en
Inactivation of C3a and C5a octapeptides by carboxypeptidase R and carboxypeptidase N.
@nl
prefLabel
Inactivation of C3a and C5a octapeptides by carboxypeptidase R and carboxypeptidase N.
@ast
Inactivation of C3a and C5a octapeptides by carboxypeptidase R and carboxypeptidase N.
@en
Inactivation of C3a and C5a octapeptides by carboxypeptidase R and carboxypeptidase N.
@nl
P2093
P2860
P1476
Inactivation of C3a and C5a octapeptides by carboxypeptidase R and carboxypeptidase N.
@en
P2093
Eliada Lazoura
Hidechika Okada
Noriko Okada
William D Campbell
P2860
P304
P356
10.1111/J.1348-0421.2002.TB02669.X
P577
2002-01-01T00:00:00Z